Therapeutic response in patients with CD30+ lymphomas to biological therapy
Introduction: Improvements in combined chemotherapy and radiotherapy of the newly diagnosed Hodgkin's lymphoma (HL) resulted in sustained remission rates of approximately 60% to 80%. However, about 5% of the early stages of the disease and 30% to 40% of advanced disease experience relapses afte...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
University of Belgrade, Medical Faculty
2020-01-01
|
| Series: | Medicinski Podmladak |
| Subjects: | |
| Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/0369-1527/2020/0369-15272004063C.pdf |